Thermo Fisher Scientific Elects New Director to Board

WALTHAM, Mass. - Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has elected Lars Rebien Sørensen to its board of directors. Mr. Sørensen's appointment brings the total number of Thermo Fisher board members to 12. Mr. Sørensen has been president and CEO of Novo Nordisk A/S, a [...]

Roche Announces Thomas Schinecker as New President of 454 Life Sciences

Branford, CT - 454 Life Sciences, a center of excellence of Roche’s (SIX: RO, ROG; OTCQX: RHHBY) business unit Applied Science, and developer of the innovative GS Junior and GS FLX+ Systems for high-throughput DNA sequencing, announced that effective August 1, 2011, Dr. Thomas Schinecker is appointed Lifecycle Leader for Sequencing and President of 454 [...]

CT3 System for Consistent Gelatin Analysis Available From Brookfield

Middleboro, MA – Brookfield Engineering laboratories now offers a complete system for performing the “Gelatin Bloom Strength Test.” This system includes Brookfield’s enhanced CT3 Texture Analyzer for measuring bloom strength, two baths and one refrigeration unit for gelatin preparation. Customers can now get the complete Gelatin Bloom Strength Test system and an industry approved glass [...]

Illumina Selected as a Preferred Service Provider for Cancer Research UK

SAN DIEGO - Illumina, Inc. (NASDAQ:ILMN) today announced that the company has been selected as a preferred service provider for Cancer Research UK, the world's leading cancer charity. Illumina will provide a range of services, beginning with whole human genome sequencing, in support of the International Cancer Genome Consortium. The consortium is seeking to obtain [...]

Advanced Photonix, Inc. Announces Phase III T-Ray 4000(R) System Sale

ANN ARBOR, Mich. - Advanced Photonix, Inc.® (NYSE Amex: API) today announced that the Naval Undersea Warfare Center (NUWC) purchased a T-Ray 4000® from its wholly-owned subsidiary, Picometrix, LLC, to be used for research and testing applications that support their mission. The purchase was made via a Phase III contract which is a continuation from [...]

Proteom Sciences and Buck Institute to Develop Biomarker Tests to Improve Breast Cancer Treatment

London, UK & Novato, California; Proteome Sciences plc (“Proteome”) a global leader in biomarkers will collaborate with Buck Institute for Research on Aging (“Buck”) to develop personalized molecular tests for estrogen receptor alpha (ERa) aimed at improving outcomes in breast cancer. Under the agreement, Proteome will support development of clinical mass spectrometry assays measuring molecular [...]

AMSBIO Moves to Support the Glycobiology Research Community

AMSBIO has announced a package of initiatives to support the Glycobiology research community following the recent announcement by Seikagaku Corporation that they plan to discontinue their research reagents and glycobiology biochemicals business as of September 30th 2011. As a specialist in high purity reagents for glycobiology and glycoanalysis for over 20 years - AMSBIO has [...]

Agilent Technologies Offers Grants for Research in Integrated Biology

SANTA CLARA Calif. - Agilent Technologies Inc. (NYSE: A) today announced that it is accepting entries for two systems biology research grants, both intended to spur development of open source data-integration tools. Each grant will provide $75,000 to a single academic or non-profit research lab in 2011. Grant 1: Validating Protein Pathway Information - Integrating [...]

Molecular Devices Continues to Lead the Way in Quality Control and Validation Compliance With a New ISO/IEC 17025 Accreditation

SUNNYVALE, Calif. - Molecular Devices, LLC, a leader in bioanalytical systems for drug discovery & development, life science research, and bioassay/test development, today announced that the American Association for Laboratory Accreditation (A2LA) has accredited the Laboratory Quality System under ISO/IEC 17025 for validation plate calibration and re-calibration processes. Molecular Devices is one of the first [...]

DVS Sciences Raises $14.6 Million in Series A Financing to Advance Commercialization of Novel Single-Cell Analysis Technology

Toronto, Canada and Sunnyvale CA, USA – DVS Sciences, Inc., a privately held innovator and manufacturer of highly multi-parameter single-cell analyzers and reagents for biological research and clinical applications, announced today that it has secured US $14.6 million in a Series A venture financing round. The proceeds will be used to accelerate the company’s commercial [...]

Access IBO on Knowledge Center